Incyte (INCY) EBITDA (2016 - 2025)
Historic EBITDA for Incyte (INCY) over the last 16 years, with Q4 2025 value amounting to $335.9 million.
- Incyte's EBITDA rose 1139.12% to $335.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.5 billion, marking a year-over-year increase of 236856.4%. This contributed to the annual value of $1.5 billion for FY2025, which is 236856.4% up from last year.
- Incyte's EBITDA amounted to $335.9 million in Q4 2025, which was up 1139.12% from $443.5 million recorded in Q3 2025.
- Over the past 5 years, Incyte's EBITDA peaked at $530.3 million during Q2 2025, and registered a low of -$478.1 million during Q2 2024.
- Its 5-year average for EBITDA is $168.1 million, with a median of $166.7 million in 2023.
- Its EBITDA has fluctuated over the past 5 years, first skyrocketed by 432001.5% in 2021, then crashed by 34673.86% in 2024.
- Incyte's EBITDA (Quarter) stood at $110.7 million in 2021, then tumbled by 36.7% to $70.1 million in 2022, then skyrocketed by 167.17% to $187.3 million in 2023, then skyrocketed by 61.0% to $301.5 million in 2024, then rose by 11.39% to $335.9 million in 2025.
- Its EBITDA stands at $335.9 million for Q4 2025, versus $443.5 million for Q3 2025 and $530.3 million for Q2 2025.